CASBF
Price
$6.60
Change
+$0.62 (+10.37%)
Updated
Sep 17 closing price
Capitalization
2.12B
CPHRF
Price
$11.12
Change
-$0.34 (-2.97%)
Updated
Sep 30 closing price
Capitalization
281.82M
36 days until earnings call
Interact to see
Advertisement

CASBF vs CPHRF

Header iconCASBF vs CPHRF Comparison
Open Charts CASBF vs CPHRFBanner chart's image
CANSINO BIOLOGICS
Price$6.60
Change+$0.62 (+10.37%)
Volume$115
Capitalization2.12B
Cipher Pharmaceuticals
Price$11.12
Change-$0.34 (-2.97%)
Volume$2.55K
Capitalization281.82M
CASBF vs CPHRF Comparison Chart in %
Loading...
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CASBF vs. CPHRF commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CASBF is a Buy and CPHRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 01, 2025
Stock price -- (CASBF: $6.60 vs. CPHRF: $11.46)
Brand notoriety: CASBF and CPHRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CASBF: 68% vs. CPHRF: 13%
Market capitalization -- CASBF: $2.12B vs. CPHRF: $281.82M
CASBF [@Pharmaceuticals: Generic] is valued at $2.12B. CPHRF’s [@Pharmaceuticals: Generic] market capitalization is $281.82M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CASBF’s FA Score shows that 1 FA rating(s) are green whileCPHRF’s FA Score has 2 green FA rating(s).

  • CASBF’s FA Score: 1 green, 4 red.
  • CPHRF’s FA Score: 2 green, 3 red.
According to our system of comparison, CPHRF is a better buy in the long-term than CASBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CASBF’s TA Score shows that 2 TA indicator(s) are bullish while CPHRF’s TA Score has 3 bullish TA indicator(s).

  • CASBF’s TA Score: 2 bullish, 3 bearish.
  • CPHRF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CASBF and CPHRF are a bad buy in the short-term.

Price Growth

CASBF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CPHRF (@Pharmaceuticals: Generic) price change was -7.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.69%. For the same industry, the average monthly price growth was +45.06%, and the average quarterly price growth was +96.58%.

Reported Earning Dates

CPHRF is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.69% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CASBF($2.12B) has a higher market cap than CPHRF($282M). CASBF YTD gains are higher at: 64.959 vs. CPHRF (14.991). CPHRF has higher annual earnings (EBITDA): 16.7M vs. CASBF (-1.88B). CASBF has more cash in the bank: 4.02B vs. CPHRF (11.3M). CPHRF has less debt than CASBF: CPHRF (25.5M) vs CASBF (2.12B). CASBF has higher revenues than CPHRF: CASBF (359M) vs CPHRF (47.6M).
CASBFCPHRFCASBF / CPHRF
Capitalization2.12B282M753%
EBITDA-1.88B16.7M-11,277%
Gain YTD64.95914.991433%
P/E RatioN/A24.17-
Revenue359M47.6M754%
Total Cash4.02B11.3M35,531%
Total Debt2.12B25.5M8,306%
FUNDAMENTALS RATINGS
CPHRF: Fundamental Ratings
CPHRF
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CASBFCPHRF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
43%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POSAX9.02N/A
N/A
Principal Global Real Estate Sec A
PGICX18.33N/A
N/A
Virtus KAR Equity Income C
GMXPX25.27N/A
N/A
Goldman Sachs Large Cp Val Insghts P
FSWAX11.27N/A
N/A
Fidelity Advisor Sustainable EM Eq A
DFEMX35.40N/A
N/A
DFA Emerging Markets I

CASBF and

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
+32.04%
CNTMF - CASBF
2%
Poorly correlated
+11.70%
BUDZ - CASBF
2%
Poorly correlated
+14.10%
CBWTF - CASBF
1%
Poorly correlated
+3.81%
CPHRF - CASBF
0%
Poorly correlated
N/A
More

CPHRF and

Correlation & Price change

A.I.dvisor tells us that CPHRF and OGI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHRF and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHRF
1D Price
Change %
CPHRF100%
N/A
OGI - CPHRF
23%
Poorly correlated
+16.57%
SDZNY - CPHRF
21%
Poorly correlated
+1.67%
CBWTF - CPHRF
8%
Poorly correlated
+3.81%
CANQF - CPHRF
6%
Poorly correlated
N/A
CURLF - CPHRF
5%
Poorly correlated
+37.02%
More